Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma <it>in situ</it>

Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma <it>in situ</it>

<p>Abstract</p> <p>Background</p> <p>Endocrine therapy is commonly recommended in the adjuvant setting for patients as treatment for ductal carcinoma <it>in situ </it>(DCIS). However, it is unknown whether a neoadjuvant (preoperative) anti-estrogen approach...

Full description

Bibliographic Details
Main Authors: Shim Veronica, Chin Koei, Swain Rebecca, Lessing Juan, Anderson Joseph, DeVries Sandy, Chen Yunn-Yi, Esserman Laura J, Waldman Frederic M, Hwang E Shelley
Format: Article
Language:English
Published: BMC 2009-08-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/9/285

Similar Items

Similar Items